文献速递慢阻肺

支气管扩张-类风湿关节炎重叠综合征是支气管扩张患者死亡的独立危险因素:一项多中心队列研究

Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study.
PubMed 文献 · Chest · 2017-01-16

本研究基于六个中心1716例成人支气管扩张患者的BSI数据库,评估支气管扩张与类风湿关节炎重叠综合征(BROS)是否比其他病因导致更差结局。BROS占队列8.5%,与死亡率显著相关,但不增加急性加重或住院率;BROS和BCOS死亡率均显著高于其他病因。

要点

  • BROS患者占支气管扩张队列8.5%,与死亡率显著相关。
  • BROS不增加支气管扩张急性加重频率或相关住院率。
  • BCOS患者BSI评分、铜绿假单胞菌定植率和既往住院率更高。

核心结论

  • BROS和BCOS两组患者均存在超额死亡率,需进一步研究以理解其机制。

研究设计与样本

  • 多中心队列研究,基于六个中心1716例成人支气管扩张患者的BSI数据库。
  • 患者分为BROS(无间质性肺病的RA合并BR)、特发性BR、BCOS和其他病因BR四组。

主要发现

  • 共识别147例BROS患者,占队列8.5%。
  • 平均随访48个月死亡率:特发性BR 9.3%,其他病因BR 8.6%,RA 18%,BCOS 28.5%。
  • BROS和BCOS患者死亡率显著高于所有其他病因患者。
  • BROS与死亡率存在统计学显著关系,但与更高急性加重率或BR相关住院率无关。
  • BROS患者BSI评分统计学上但非临床显著高于特发性BR(均值7.7 vs 7.1,P < .05)。

关键数值与推荐

  • BCOS患者BSI评分显著更高(均值10.4),铜绿假单胞菌定植率24%,既往住院率58%。

临床怎么用

  • 对支气管扩张合并类风湿关节炎(无间质性肺病)患者应识别为BROS,关注其超额死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study assessed if bronchiectasis (BR) and rheumatoid arthritis (RA), when manifesting as an overlap syndrome (BROS), were associated with worse outcomes than other BR etiologies applying the Bronchiectasis Severity Index (BSI). METHODS: Data were collected from the BSI databases of 1,716 adult patients with BR across six centers: Edinburgh, United Kingdom (608 patients); Dundee, United Kingdom (n = 286); Leuven, Belgium (n = 253); Monza, Italy (n = 201); Galway, Ireland (n = 242); and Newcastle, United Kingdom (n = 126). Patients were categorized as having BROS (those with RA and BR without interstitial lung disease), idiopathic BR, bronchiectasis-COPD overlap syndrome (BCOS), and "other" BR etiologies. Mortality rates, hospitalization, and exacerbation frequency were recorded. RESULTS: A total of 147 patients with BROS (8.5% of the cohort) were identified. There was a statistically significant relationship between BROS and mortality, although this relationship was not associated with higher rates of BR exacerbations or BR-related hospitalizations. The mortality rate over a mean of 48 months was 9.3% for idiopathic BR, 8.6% in patients with other causes of BR, 18% for RA, and 28.5% for BCOS. Mortality was statistically higher in patients with BROS and BCOS compared with those with all other etiologies. The BSI scores were statistically but not clinically significantly higher in those with BROS compared with those with idiopathic BR (BSI mean, 7.7 vs 7.1, respectively; P < .05). Patients with BCOS had significantly higher BSI scores (mean, 10.4), Pseudomonas aeruginosa colonization rates (24%), and previous hospitalization rates (58%). CONCLUSIONS: Both the BROS and BCOS groups have an excess of mortality. The mechanisms for this finding may be complex, but these data emphasize that these subgroups require additional study to understand this excess mortality.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. De Soyza A, McDonnell MJ, Goeminne PC, et al. Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study. Chest. 2017. PMID: 28093268. doi:10.1016/j.chest.2016.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。